4//SEC Filing
Stromatt Scott C 4
Accession 0001019056-19-000184
CIK 0001671584other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:09 PM ET
Size
10.9 KB
Accession
0001019056-19-000184
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Exercise/Conversion
Restricted Stock Unit
2019-03-01−16,269→ 0 total→ Common Stock (16,269 underlying) - Award
Stock Option (right to buy)
2019-02-28+67,400→ 67,400 totalExercise: $1.52Exp: 2029-02-28→ Common Stock (67,400 underlying) - Exercise/Conversion
Common Stock
2019-03-01+16,269→ 221,006 total - Tax Payment
Common Stock
2019-03-01$1.57/sh−4,823$7,572→ 216,183 total
Footnotes (3)
- [F1]Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.
- [F2]The option vests in three approximately equal annual installments beginning on February 28, 2020.
- [F3]The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679975
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:09 PM ET
- Size
- 10.9 KB